Lantern Pharma Inc.
LTRNNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for LTRN. That does not mean none is planned.
Get an email about LTRN's next catalysts
Track Lantern Pharma (LTRN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
LTRN Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
How LTRN's past catalysts played out
Market Overview
Stock performance and key metrics
Tavocept(BNP7787) in combination with cisplatin and either docetaxel or paclitaxel
Non-small Cell Lung Cancer
LP-184
Advanced Solid Tumor
LP-300
Adenocarcinoma of Lung
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Tavocept(BNP7787) in combination with cisplatin and either docetaxel or paclitaxel | Phase 3 | Non-small Cell Lung Cancer | - | - |
LP-184 | Phase 2 | Advanced Solid Tumor | - | - |
LP-300 | Phase 2 | Adenocarcinoma of Lung | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Lantern Pharma Inc.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in Lantern Pharma Inc.'s (LTRN) pipeline across Phase 3, Phase 2. Its lead program is Tavocept(BNP7787) in combination with cisplatin and either docetaxel or paclitaxel (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Lantern Pharma Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Lantern Pharma Inc. (LTRN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track LTRN biotech catalysts?→
Add LTRN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Lantern Pharma Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.